CHUV
Les activités du CHUV
MENU
Centre du sein
Accueil > Recherche > Publications > Publications 2016

Publications 2016


1

Favez N, Cairo Notari S, Charvoz L, Notari L, Ghisletta P, Panes Ruedin B, Delaloye JF.

Distress and body image disturbances in women with breast cancer in the immediate postsurgical period: The influence of attachment insecurity.

J Health Psychol. 2016 Dec;21(12):2994-3003. Epub 2015 Jun 19.

PubMed PMID:26092841


2

Rochlitz C, Bigler M, von Moos R, Bernhard J, Matter-Walstra K, Wicki A, Zaman K, Anchisi S, Küng M, Na KJ, Bärtschi D, Borner M, Rordorf T, Rauch D, Müller A, Ruhstaller T, Vetter M, Trojan A, Hasler-

SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial.

Strub U, Cathomas R, Winterhalder R; Swiss Group for Clinical Cancer Research (SAKK).

BMC Cancer. 2016 Oct 10;16(1):780.PubMed PMID:27724870


3

Rageth CJ, O'Flynn EA, Comstock C, Kurtz C, Kubik R, Madjar H, Lepori D, Kampmann G, Mundinger A, Baege A, Decker T, Hosch S, Tausch C, Delaloye JF, Morris E, Varga Z.

First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).

Breast Cancer Res Treat. 2016 Sep;159(2):203-13. doi: 10.1007/s10549-016-3935-4. Epub 2016 Aug 13. Review. PubMed PMID:27522516


4

Zurcher JP(1), Stravodimou A(1), Zaman K(1)

Hormone therapy in invasive breast cancer : update 2016

Rev Med Suisse. 2016 Sep 21;12(531):1580-1583.


5

Lopez VA, Stravodimou A, Unger S, Perey L, Zaman K.

BRCA mutations: from Angelina Jolie to specific therapies

Rev Med Suisse. 2016 May 18;12(519):973-4, 976-7. French.


6

Phillips KA, Regan MM, Ribi K, Francis PA, Puglisi F, Bellet M, Spazzapan S, Karlsson P, Budman DR, Zaman K, Abdi EA, Domchek SM, Feng Y, Price KN, Coates AS, Gelber RD, Maruff P, Boyle F, Forbes JF, Ahles T, Fleming GF, Bernhard J

Adjuvant ovarian function suppression and cognitive function in women with breast cancer.

Br J Cancer. 2016 Apr 26;114(9):956-64. doi: 10.1038/bjc.2016.71. Epub 2016 Apr 19.


7

Sflomos G, Dormoy V, Metsalu T, Jeitziner R, Battista L, Scabia V, Raffoul W, Delaloye JF, Treboux A, Fiche M, Vilo J, Ayyanan A, Brisken C.

A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response.

Cancer Cell. 2016 Mar 14;29(3):407-22. doi: 10.1016/j.ccell.2016.02.002. Epub 2016 Mar 3.


8

Cairo Notari S, Favez N, Notari L, Charvoz L, Delaloye JF.

The caregiver burden in male romantic partners of women with non-metastatic breast cancer: The protective role of couple satisfaction.

J Health Psychol. 2016 Mar 3. pii: 1359105316633285.

9

Prior JO, Péguret N, Pomoni A, Pappon M, Zeverino M, Belmondo B, Lovis A, Ozsahin M, Vienne M, Bourhis J.

Reduction of Respiratory Motion During PET/CT by Pulsatile-Flow Ventilation: A First Clinical Evaluation.

J Nucl Med. 2016 Mar;57(3):416-9. doi: 10.2967/jnumed.115.163386. Epub 2015 Dec 3.

10

Forbes JF, Sestak I, Howell A, Bonanni B, Bundred N, Levy C, von Minckwitz G, Eiermann W, Neven P, Stierer M, Holcombe C, Coleman RE, Jones L, Ellis I, Cuzick J; IBIS-II investigators.

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.

Lancet. 2016 Feb 27;387(10021):866-73. doi: 10.1016/S0140-6736(15)01129-0. Epub 2015 Dec 11.

11

Péguret N, Ozsahin M, Zeverino M, Belmondo B, Durham AD, Lovis A, Simons J, Long O, Duclos F, Prior J, Denys A, Beigelman C, Sozzi WJ, Grant K, Gautier-Dechaud V, Peters S, Vienne M, Moeckli R, Bourhis J.

Apnea-like suppression of respiratory motion: First evaluation in radiotherapy.

Radiother Oncol. 2016 Feb;118(2):220-6. doi: 10.1016/j.radonc.2015.10.011.

12

Dupouy DG, Ciftlik AT, Fiche M, Heintze D, Bisig B, de Leval L, Gijs MA.

Continuous quantification of HER2 expression by microfluidic precision immunofluorescence estimates HER2 gene amplification in breast cancer.

Sci Rep. 2016 Feb 9;6:20277. doi: 10.1038/srep20277.

13

Mazzocato C.

Palliative care: a death sentence or hope? When do you talk about it?

Rev Med Suisse. 2016 Jan 27;12(503):194-5. French. No abstract available.